Editorial: Tumor microenvironment and personalized therapy of gastrointestinal cancer Ⅱ - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Editorial: The Role of Tumor Microenvironment in Tailored Treatments for Gastrointestinal Cancer II

  • By

  • Xinxin Wang

  • Jianming James Tang

  • Shuang Yang

  • Shuo Li

  • September 8, 2026

Share

  • 1

    Gastrointestinal cancers exhibit significant biological and clinical heterogeneity, complicating diagnosis and treatment.

  • 2

    The tumor microenvironment and systemic host status are critical in understanding cancer beyond intrinsic tumor characteristics.

  • 3

    A multidimensional approach integrating tumor features and host conditions may enhance risk assessment and management.

  • 4

    The C-reactive protein-to-albumin ratio on postoperative day 3 is a potential biomarker for predicting complications after gastric cancer surgery.

  • 5

    Prognostic indices like the pan-immune-inflammation value and C-reactive protein-albumin-lymphocyte index show promise in stratifying risk in gastrointestinal cancers.

Original Source(s)

Editorial: Tumor microenvironment and personalized therapy of gastrointestinal cancer Ⅱ

  • by Xinxin Wang, Jianming James Tang, Shuang Yang, Shuo Li

  • September 8, 2026

Related Content

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.

  • by

  • September 4, 2026

  • 4 min
Case Report: Possible spatially-distinct de novo invasive cervical carcinoma in the setting of isolated persistent HPV16 after ALA-PDT-mediated histological clearance of CIN3